4-[4-[(2S,5S,8R,11S,14S)-8,11-dibenzyl-7-methyl-3,6,9,12,15-pentaoxo-14-[4-(phenylmethoxycarbonylamino)butyl]-5-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]butylcarbamoyl]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid

C65H69N7O13 — CID 57396686

IUPAC4-[4-[(2S,5S,8R,11S,14S)-8,11-dibenzyl-7-methyl-3,6,9,12,15-pentaoxo-14-[4-(phenylmethoxycarbonylamino)butyl]-5-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]butylcarbamoyl]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid
SMILESCC(C)[C@@H]1NC(=O)[C@H](CCCCNC(=O)c2ccc(C(=O)O)c(-c3c4ccc(=O)cc-4oc4cc(O)ccc34)c2)NC(=O)[C@H](CCCCNC(=O)OCc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)N(C)C1=O
InChIInChI=1S/C65H69N7O13/c1-39(2)57-63(80)72(3)53(34-41-19-9-5-10-20-41)62(79)70-52(33-40-17-7-4-8-18-40)61(78)69-50(23-14-16-32-67-65(83)84-38-42-21-11-6-12-22-42)59(76)68-51(60(77)71-57)24-13-15-31-66-58(75)43-25-28-46(64(81)82)49(35-43)56-47-29-26-44(73)36-54(47)85-55-37-45(74)27-30-48(55)56/h4-12,17-22,25-30,35-37,39,50-53,57,73H,13-16,23-24,31-34,38H2,1-3H3,(H,66,75)(H,67,83)(H,68,76)(H,69,78)(H,70,79)(H,71,77)(H,81,82)/t50-,51-,52-,53+,57-/m0/s1
InChIKeyHTEQXZRMZGOGFL-PDDPGEDESA-N
MW1156.30 g/mol
LogP6.89
Rot. Bonds20

About 4-[4-[(2S,5S,8R,11S,14S)-8,11-dibenzyl-7-methyl-3,6,9,12,15-pentaoxo-14-[4-(phenylmethoxycarbonylamino)butyl]-5-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]butylcarbamoyl]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid

4-[4-[(2S,5S,8R,11S,14S)-8,11-dibenzyl-7-methyl-3,6,9,12,15-pentaoxo-14-[4-(phenylmethoxycarbonylamino)butyl]-5-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]butylcarbamoyl]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid (PubChem CID 57396686) has the molecular formula C65H69N7O13 and a molecular weight of 1156.30 g/mol. Its IUPAC name is 4-[4-[(2S,5S,8R,11S,14S)-8,11-dibenzyl-7-methyl-3,6,9,12,15-pentaoxo-14-[4-(phenylmethoxycarbonylamino)butyl]-5-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]butylcarbamoyl]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid.

Molecular Properties

Compound Name4-[4-[(2S,5S,8R,11S,14S)-8,11-dibenzyl-7-methyl-3,6,9,12,15-pentaoxo-14-[4-(phenylmethoxycarbonylamino)butyl]-5-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]butylcarbamoyl]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid
PubChem CID57396686
Molecular FormulaC65H69N7O13
Molecular Weight1156.30 g/mol
Exact Mass1155.50
IUPAC Name4-[4-[(2S,5S,8R,11S,14S)-8,11-dibenzyl-7-methyl-3,6,9,12,15-pentaoxo-14-[4-(phenylmethoxycarbonylamino)butyl]-5-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]butylcarbamoyl]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid
SMILESCC(C)[C@@H]1NC(=O)[C@H](CCCCNC(=O)c2ccc(C(=O)O)c(-c3c4ccc(=O)cc-4oc4cc(O)ccc34)c2)NC(=O)[C@H](CCCCNC(=O)OCc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)N(C)C1=O
InChIInChI=1S/C65H69N7O13/c1-39(2)57-63(80)72(3)53(34-41-19-9-5-10-20-41)62(79)70-52(33-40-17-7-4-8-18-40)61(78)69-50(23-14-16-32-67-65(83)84-38-42-21-11-6-12-22-42)59(76)68-51(60(77)71-57)24-13-15-31-66-58(75)43-25-28-46(64(81)82)49(35-43)56-47-29-26-44(73)36-54(47)85-55-37-45(74)27-30-48(55)56/h4-12,17-22,25-30,35-37,39,50-53,57,73H,13-16,23-24,31-34,38H2,1-3H3,(H,66,75)(H,67,83)(H,68,76)(H,69,78)(H,70,79)(H,71,77)(H,81,82)/t50-,51-,52-,53+,57-/m0/s1
InChIKeyHTEQXZRMZGOGFL-PDDPGEDESA-N
XLogP6.89
TPSA291.88 Ų
H-Bond Donors8
H-Bond Acceptors12
Rotatable Bonds20
Heavy Atoms85
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001156.30
LogP ≤ 56.89
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'Polycyclic_aromatic_hydrocarbon_2', 'substructure': 'N/A'}

Analyze 4-[4-[(2S,5S,8R,11S,14S)-8,11-dibenzyl-7-methyl-3,6,9,12,15-pentaoxo-14-[4-(phenylmethoxycarbonylamino)butyl]-5-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]butylcarbamoyl]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-[4-[(2S,5S,8R,11S,14S)-8,11-dibenzyl-7-methyl-3,6,9,12,15-pentaoxo-14-[4-(phenylmethoxycarbonylamino)butyl]-5-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]butylcarbamoyl]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid?
The IUPAC name of 4-[4-[(2S,5S,8R,11S,14S)-8,11-dibenzyl-7-methyl-3,6,9,12,15-pentaoxo-14-[4-(phenylmethoxycarbonylamino)butyl]-5-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]butylcarbamoyl]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid (CID 57396686) is 4-[4-[(2S,5S,8R,11S,14S)-8,11-dibenzyl-7-methyl-3,6,9,12,15-pentaoxo-14-[4-(phenylmethoxycarbonylamino)butyl]-5-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]butylcarbamoyl]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid.
What is the SMILES notation for 4-[4-[(2S,5S,8R,11S,14S)-8,11-dibenzyl-7-methyl-3,6,9,12,15-pentaoxo-14-[4-(phenylmethoxycarbonylamino)butyl]-5-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]butylcarbamoyl]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid?
The canonical SMILES for 4-[4-[(2S,5S,8R,11S,14S)-8,11-dibenzyl-7-methyl-3,6,9,12,15-pentaoxo-14-[4-(phenylmethoxycarbonylamino)butyl]-5-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]butylcarbamoyl]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid is CC(C)[C@@H]1NC(=O)[C@H](CCCCNC(=O)c2ccc(C(=O)O)c(-c3c4ccc(=O)cc-4oc4cc(O)ccc34)c2)NC(=O)[C@H](CCCCNC(=O)OCc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)N(C)C1=O.
What is the InChIKey of 4-[4-[(2S,5S,8R,11S,14S)-8,11-dibenzyl-7-methyl-3,6,9,12,15-pentaoxo-14-[4-(phenylmethoxycarbonylamino)butyl]-5-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]butylcarbamoyl]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid?
The InChIKey is HTEQXZRMZGOGFL-PDDPGEDESA-N. The full InChI is InChI=1S/C65H69N7O13/c1-39(2)57-63(80)72(3)53(34-41-19-9-5-10-20-41)62(79)70-52(33-40-17-7-4-8-18-40)61(78)69-50(23-14-16-32-67-65(83)84-38-42-21-11-6-12-22-42)59(76)68-51(60(77)71-57)24-13-15-31-66-58(75)43-25-28-46(64(81)82)49(35-43)56-47-29-26-44(73)36-54(47)85-55-37-45(74)27-30-48(55)56/h4-12,17-22,25-30,35-37,39,50-53,57,73H,13-16,23-24,31-34,38H2,1-3H3,(H,66,75)(H,67,83)(H,68,76)(H,69,78)(H,70,79)(H,71,77)(H,81,82)/t50-,51-,52-,53+,57-/m0/s1.
What are the key properties of 4-[4-[(2S,5S,8R,11S,14S)-8,11-dibenzyl-7-methyl-3,6,9,12,15-pentaoxo-14-[4-(phenylmethoxycarbonylamino)butyl]-5-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]butylcarbamoyl]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid?
4-[4-[(2S,5S,8R,11S,14S)-8,11-dibenzyl-7-methyl-3,6,9,12,15-pentaoxo-14-[4-(phenylmethoxycarbonylamino)butyl]-5-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]butylcarbamoyl]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid has a molecular weight of 1156.30 g/mol, XLogP of 6.89, 20 rotatable bonds, 8 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[4-[(2S,5S,8R,11S,14S)-8,11-dibenzyl-7-methyl-3,6,9,12,15-pentaoxo-14-[4-(phenylmethoxycarbonylamino)butyl]-5-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]butylcarbamoyl]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid is sourced from PubChem (CID 57396686), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).